Welcome to our dedicated page for HEALWELL AI A SUB VTG news (Ticker: HWAIF), a resource for investors and traders seeking the latest updates and insights on HEALWELL AI A SUB VTG stock.
HEALWELL AI Inc. develops and commercializes healthcare artificial intelligence software for preventative care, with a focus on clinical decision support, early disease identification, and workflow tools for healthcare providers. News about HWAIF commonly covers the company’s DARWEN™ AI platform, Smart Search, Smart Summary, Smart ID, and the use of AI-enriched clinical data to support real-world evidence across disease areas.
Company updates also include revenue and Adjusted EBITDA reporting, integration of Orion Health, enterprise health-system and Health Information Exchange software contracts, customer renewals, scientific publications, conference participation, and board or governance changes. HEALWELL trades on the Toronto Stock Exchange as AIDX and on the OTCQX market as HWAIF.
HEALWELL AI (OTCQX: HWAIF) appointed Brad Porter to its Board of Directors effective April 22, 2026, strengthening commercial and strategic leadership.
Porter, HEALWELL chief commercial officer and CEO of Orion Health, brings over 15 years of finance and global healthcare technology experience. Ian McCrae is stepping down after the Orion Health integration.
HEALWELL (OTCQX:HWAIF) will present at the 2026 Bloom Burton & Co. Healthcare Investor Conference in Toronto on April 21-22, 2026. Presentation: April 22, 2026, 2:00–2:30 PM ET. CEO James Lee and President Dr. Alexander Dobranowski will attend and hold one-on-one investor meetings.
The company will deliver a corporate presentation and take part in 1-on-1 meetings; investors should contact Bloom Burton representatives to schedule meetings.
HEALWELL AI (OTCQX: HWAIF) reported record fiscal 2025 results with $103.8M revenue, a 427% increase year-over-year, and its first full year of positive Adjusted EBITDA at $2.3M. The company reported an IFRS net loss of $39.1M and ended the year with $18.6M cash.
HEALWELL completed strategic divestments generating $9.7M in cash, integrated Orion Health, and highlighted DARWEN's scientific validation with 47 peer-reviewed publications.
HEALWELL AI (OTCQX:HWAIF) announced its 47th peer-reviewed publication validating the DARWEN™ AI platform, with new research published in the Journal of Crohn's and Colitis and presented at ECCO on March 12, 2026. HEALWELL also secured three additional 2026 conference acceptances across diabetes, dermatology and IBD.
The studies show DARWEN™ can transform unstructured EHR data into research-ready real-world evidence, analyze millions of clinical records, and support Medical Affairs and market access initiatives with pharmaceutical partners.
HEALWELL AI (TSX: AIDX) (OTCQX: HWAIF) will release its Fiscal Fourth Quarter and Year End 2025 financial results for the period ended December 31, 2025, on March 19, 2026. A conference call and simultaneous webcast to discuss results will be held on March 20, 2026 at 8:30 AM ET.
Management hosting the call: James Lee, Chief Executive Officer; Dr. Alexander Dobranowski, President; and Anthony Lam, Chief Financial Officer. Webcast and dial-in details provided for live access.
HEALWELL AI (OTCQX: HWAIF) announced a signed multi‑million dollar, multi‑year U.S. Health Information Exchange (HIE) software contract, expanding its enterprise interoperability footprint and supporting secure data exchange for millions of patient lives.
The company reported renewed pipeline momentum, coordinated Orion Health and VeroSource bid activity, and integration of SMART Identify, SMART Search and SMART Summary into the Amadeus AI platform to drive enterprise AI commercialization.
HEALWELL (OTCQX:HWAIF) will participate in three investor conferences in March 2026: TD Cowen (Boston, Mar 2-4), Scotiabank TMT (Toronto, Mar 3-4) and ROTH (Dana Point, Mar 22-24).
Dr. Alexander Dobranowski will present and hold investor meetings, including a TD Cowen presentation on Mar 3 and a ROTH panel on Mar 23 titled Technologies Advancing Healthy Aging.
HEALWELL AI (OTCQX:HWAIF) announced its first contracted AI deployment in the Middle East and expanded active deployments across Canada and the United States on February 26, 2026. The Company is deploying SMART Identify, SMART Search, and SMART Summary in multiple healthcare systems, marking cross‑border commercial momentum and platform scalability.
HEALWELL says deployments span frontline care environments and that contracted revenue now exists across Canada, the U.S., and the Middle East, while the company reports a growing pipeline for broader enterprise expansion.
HEALWELL AI (OTCQX: HWAIF) and WELL Health launched WELLTRUST™ on February 19, 2026, a consent-first data governance and patient-identification platform deployed across WELL-operated clinics in Canada. WELLTRUST uses patient-controlled consent and HEALWELL's DARWEN™ AI to identify high-fit patients for clinical trials while preserving privacy and compliance.
The platform supports contact consent, unified privacy controls, AI-enabled recruitment, and a governance layer to meet Canadian regulatory standards.
HEALWELL AI (OTCQX: HWAIF) provided a corporate update on February 12, 2026, outlining platform integration, product rollouts and portfolio simplification.
The company unified Khure and Pentavere into a DARWEN-powered AI engine, plans a North American Amadeus AI launch in 1H-26 (international late 2026), reports early commercial traction via Orion-Verosource initiatives, notes four Q4-2025 publications, and is assessing a USD $2M strategic investment vehicle holding an interest in xAI/SpaceX.